Evidence map›Paper›PMID 33997054›Full record

ArticleJournal of immunology research2021

Robust Plasma Cell Response to Skin-Inoculated Dengue Virus in Mice.

Raúl A Maqueda-Alfaro, Edith Marcial-Juárez, Juana Calderón-Amador, Julio García-Cordero, Mariana Orozco-Uribe, Felipe Hernández-Cázares, Uziel Medina-Pérez, Luvia E Sánchez-Torres, Adriana Flores-Langarica, Leticia Cedillo-Barrón and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Raúl A Maqueda-AlfaroDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.ORCID https://orcid.org/0000-0003-3538-1176
Edith Marcial-JuárezDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Juana Calderón-AmadorDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Julio García-CorderoDepartment of Molecular Biomedicine, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Mariana Orozco-UribeDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Felipe Hernández-CázaresDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Uziel Medina-PérezDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Luvia E Sánchez-TorresDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala s/n, Ciudad de México 11400, Mexico.
Adriana Flores-LangaricaInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Vincent Dr, Edgbaston B15 2TT, Birmingham, UK.
Leticia Cedillo-BarrónDepartment of Molecular Biomedicine, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Juan C Yam-PucInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Vincent Dr, Edgbaston B15 2TT, Birmingham, UK.ORCID https://orcid.org/0000-0003-4395-8844
Leopoldo Flores-RomoDepartment of Cell Biology, Center for Research and Advanced Studies, The National Polytechnic Institute, Cinvestav-IPN, Av. IPN 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360 Mexico City, Mexico.
Instituto Politécnico Nacional · MXUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue is a worldwide expanding threat caused by dengue virus (DENV) infection. To date, no specific treatment or effective vaccine is available. Antibodies produced by plasma cells (PCs) might be involved concomitantly in protection and severe dengue immunopathology. Although a massive appearance of PCs has been reported during acute DENV infection in humans, this response has been poorly characterized. Here, we show the dynamic of PC generation in immune-competent mice cutaneously inoculated with DENV compared with two control experimental groups: mice inoculated with inactivated DENV or with PBS. We found that PC numbers increased significantly in the skin-draining lymph node (DLN), peaking at day 10 and abruptly decreasing by day 14 after DENV inoculation. Class-switched IgG

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCross ReactionsDengueDengue VirusDisease Models, AnimalGerminal CenterHumansMaleMicePlasma CellsSkinSpecific Pathogen-Free OrganismsZika VirusAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID33997054
PMCPMC8096554
OpenAlexW3159514857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.